TABLE 5.
Protective effects of glucosides on vascular endothelial cells.
Monomer | Model | Dose/Concentration | Effects | Related molecular targets | References | |
---|---|---|---|---|---|---|
Upregulation | Downregulation | |||||
Sweroside | Langendorff- induced MI in Wistar rats; H/R-induced OS in H9c2 | 25, 50, 100 mg/kg; 50 µM | Reducing infarct size; improving cardiac function; partially inhibiting OS and pyroptosis | Nrf2, HO-1, NQO1 | Keap1 NLPR3, cleaved caspase-1, IL-1β | Li et al. (2021) |
Pubescenoside A | LAD-induced MI in rats; LPS plus ATP-induced injure in RAW264.7 cells; OGD/R-induced injure in H9c2 and primary cardiomyocyte cells | 30 mg/kg; 10, 30 μM | Reducing infarct size; restoring cardiac function and decreasing inflammation and OS | Nrf2, HO-1, NQO1 | Keap1, NLPR3, cleaved-caspase1, IL-1β, ACS, Caspase1 | Cheng et al. (2021) |